Clinical Trial Update: Rivaroxaban vErsus Warfarin for Antithrombotic TheRapy in Patients With LeFt Ventricular Thrombus After Acute STEMI [Phase 3]

View source ↗

Summary

Phase 3 trial comparing rivaroxaban versus warfarin for antithrombotic therapy in patients with left ventricular thrombus after acute STEMI has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Left Ventricular Thrombus
• St-segment Elevation Myocardial Infarction

Drugs mentioned

• Rivaroxaban (rivaroxaban)
• Warfarin (warfarin)

Snippet

Sponsor: Rajaie Cardiovascular Medical and Research Center | Conditions: Left Ventricular Thrombus, ST Segment Elevation Myocardial Infarction | Phase 3 | Status: COMPLETED